Gaps between Diabetes Guidelines and Clinical Practice

About the event

It is a proven fact that there is a direct link between type 2 diabetes and cardiovascular disease, being hyperglycemia the key risk factor for developing complications.

In this multidisciplinary approach, Dr. José Kerr, Cardiologist from Brazil, enlightens us on why there is a legacy effect in patients with more rigorous glycemic control - showing reductions in acute myocardial infarction, microvascular complications, and all-cause mortality – and why acknowledging the differences within the sulfonylurea classes (especially Gliclazide MR) might be the solution to effectively reduce glycated hemoglobin in patients with type 2 diabetes.

Watch the complete lecture to find out more!